Grit­stone bio se­cures PIPE fi­nanc­ing as it un­veils PhI da­ta for vac­cine can­di­date

Cal­i­for­nia biotech Grit­stone bio was giv­en an $80 mil­lion cred­it fa­cil­i­ty in the sum­mer, fol­low­ing the trend of sev­er­al biotechs ex­tend­ing cash through loans. Now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER